Related Experiment Video
Updated: Jul 5, 2026
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Immune modulation and graft protection by gene therapy in kidney transplantation
Maria Sandovici1, Leo E Deelman, Dick de Zeeuw
1Department of Clinical Pharmacology, Faculty of Medical Sciences, University Medical Center Groningen, The Netherlands. m.sandovici@med.umcg.nl
Abstract:
Kidney transplantation represents the therapy of choice for many patients with end-stage renal disease. However, the success of renal engraftment is hindered by a number of factors, the most important of which being adverse effects of systemic immunosuppressive therapy, chronic transplant dysfunction and a severe shortage of donor kidneys. Gene therapy approaches may provide valuable strategies in each of these areas. First, gene therapy holds the potential of local therapy, thus circumventing systemic side effects of chronic immunosuppression. Second, chronic transplant dysfunction may be addressed by innovative strategies to induce local immune tolerance, immune suppression and additional graft protecting mechanisms. Third, gene therapy may be instrumental in increasing the quality of the grafts by limiting ischemia-reperfusion injury, especially in non-heart beating donors, thereby expanding the donor pool. In this article, we give an overview of the current state of gene therapy in experimental models of kidney transplantation.
Insights
Gene therapy offers promising solutions for kidney transplantation by enabling local treatments to reduce immunosuppression side effects, enhance graft function, and improve donor kidney quality, addressing key challenges in end-stage renal disease therapy.
Area of Science:
- Nephrology
- Immunology
- Gene Therapy
Background:
- Kidney transplantation is the preferred treatment for end-stage renal disease.
- Graft success is limited by immunosuppression side effects, chronic dysfunction, and donor organ scarcity.
Purpose of the Study:
- To review the current applications of gene therapy in experimental kidney transplantation models.
- To explore gene therapy's potential in overcoming major transplantation barriers.
Main Methods:
- Review of existing literature on gene therapy strategies in preclinical kidney transplant models.
- Analysis of gene therapy's role in local immunosuppression, immune tolerance induction, and graft protection.
Main Results:
- Gene therapy can enable localized treatment, minimizing systemic immunosuppression adverse effects.
- It offers novel approaches for inducing immune tolerance and protecting the transplanted kidney.
- Gene therapy can mitigate ischemia-reperfusion injury, potentially expanding the donor pool.
Conclusions:
- Gene therapy presents a multifaceted strategy to improve kidney transplant outcomes.
- It holds significant potential for addressing immunosuppression, chronic dysfunction, and organ shortage in transplantation.
Related Concept Videos
01:40Cell-mediated Immune Responses
01:28Kidney Transplant I: Introduction
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
00:59Gene Therapy
01:26Kidney Transplant II: Surgical Procedure